Suraksha Diagnostic IPO is set to open on November 29, 2024, and will close on December 3, 2024. The Suraksha Diagnostic IPO is a Book Built Issue, aiming to raise approximately ₹846.25 crores. This includes a fresh issue of ₹- crores and an offer for sale of up to 1,91,89,330. The face value of each share is ₹1.
Suraksha Diagnostic IPO Price band is set between ₹420 to ₹441 per share. The quota allocation is 35% for Retail investors, 50% for Qualified institutional Buyers (QIB), and 15% for Non-Institutional Investors (HNI). Suraksha Diagnostic IPO is scheduled to list on NSE & BSE on December 6, 2024, with the allotment announcement on December 4, 2024.
The company reported revenue of ₹218.71 crores in 2024, compared to ₹190.13 crores in 2023. It posted a Profit of ₹23.13 crores in 2024, compared to a Profit of ₹6.07 crores in 2023. Based on the financials, IPO investors are advised to apply for the IPO for gains in the long term.
- Suraksha Diagnostic IPO Details
- Suraksha Diagnostics IPO Market Lot
- Suraksha Diagnostics IPO Dates
- About Suraksha Diagnostics
- Promoters of Suraksha Diagnostics
- Suraksha Diagnostics Financial Report
- Key Performance Indicator
- Peer Group Comparison
- Objective of the Issue
- Suraksha Diagnostic IPO GMP (Grey Market Premium)
- Suraksha Diagnostic Subscription Status
- Suraksha Diagnostic Allotment Status
- IPO Registrar
- IPO Lead Managers
- Suraksha Diagnostic Contact
- FAQs
Suraksha Diagnostic IPO Details
| Overview Points | Description |
|---|---|
| Company Name | Suraksha Clinic & Diagnostics |
| Industry | Healthcare |
| IPO Issue Type | Book Built Issue |
| Open Date | November 29, 2024 |
| Close Date | December 3, 2024 |
| Total Issue Size | Approx. ₹846.25 Crores |
| Fresh Issue | – |
| Face Value | ₹2 Per Equity Share |
| Price Band | ₹420 to ₹441 Per Share |
| Listing on | NSE & BSE |
| Lot Size | 34 Shares Per Lot |
| Offer for Sale | Approx 1,91,89,330 Equity Shares |
| Shares Offered to Retail | 35% |
| Shares Offered to QIB | 50% |
| Shares Offered to HNI | 15% |
Suraksha Diagnostics IPO Market Lot
Suraksha Diagnostics IPO has a minimum lot size of 34 shares, with an amount of ₹14,994. Retail investors can apply for up to 13 lots with 442 shares or ₹1,94,922.
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 34 | ₹14,994 |
| Retail Maximum | 13 | 442 | ₹1,94,922 |
| S-HNI Minimum | 14 | 476 | ₹2,09,916 |
| S-HNI Maximum | 66 | 2,244 | ₹9,89,604 |
| B-HNI Minimum | 67 | 2,278 | ₹1,004,598 |
Suraksha Diagnostics IPO Dates
Suraksha Diagnostics IPO opens on November 29, 2024, and closes on December 3, 2024. The allotment will be announced on December 4, 2024, and the IPO will be listed on December 6, 2024.
| Events | Date |
|---|---|
| IPO Open Date | November 29, 2024 |
| IPO Close Date | December 3, 2024 |
| Basis of Allotment | December 4, 2024 |
| Refunds | December 5, 2024 |
| Credit to Demat Account | December 5, 2024 |
| IPO Listing Date | December 6, 2024 |
About Suraksha Diagnostics
Suraksha Diagnostic, established on March 15, 2005, provides medical testing, diagnostic solutions, and medical consultations. Based in East India, it offers comprehensive pathology and radiology testing services through a well-established network. The company has received several awards for its focus and brand recognition. Its portfolio includes over 2,300 tests, such as 788 basic pathology tests (e.g., biochemistry and hematology) and 647 advanced tests (e.g., histopathology, molecular pathology).
Between FY 2022 and FY 2024, Suraksha achieved a revenue CAGR of 20.87%, with a net income of ₹23.13 crore in FY 2024. The company is a leading diagnostic network in Eastern India, known for its profitability, financial consistency, and strong expertise, supported by 1,522 permanent employees.
Promoters of Suraksha Diagnostics
- Dr. Somnath Chatterjee
- Mrs. Ritu Mittal
- Mr. Satish Kumar Verma
Suraksha Diagnostics Financial Report
| Period Ended | 30 Jun 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 314.20 | 300.21 | 281.20 | 275.96 |
| Revenue | 61.85 | 222.26 | 193.69 | 225.77 |
| Profit After Tax | 7.67 | 23.13 | 6.07 | 20.82 |
| Net Worth | 187.05 | 179.41 | 155.93 | 145.84 |
| Reserves and Surplus | 176.80 | 170.88 | 147.40 | 137.31 |
| Total Borrowing | 7.57 | 8.64 | 14.01 | 19.03 |
| Amount in ₹ Crores | ||||
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE: | 14.09% |
| ROCE: | 21.46% |
| EBITDA Margin: | 33.66% |
| PAT Margin: | 10.57% |
| Debt to equity ratio: | 0.20 |
| Earning Per Share (EPS): | ₹4.43 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 14.09% |
| Net Asset Value (NAV): | ₹33.66 |
Peer Group Comparison
| Company Name | EPS | NAV | PE Ratio | RoNW (%) |
|---|---|---|---|---|
| Dr Lal PathLabs | 43.05 | 221.47 | 77.08 | 20.35 |
| Metropolis Healthcare | 24.95 | 213.98 | 89.61 | 12.26 |
| Thyrocare Technologies | 13.42 | 99.48 | 65.52 | 13.34 |
| Vijaya Diagnostic Centre | 11.62 | 64.21 | 86.40 | 19.77 |
Objective of the Issue
- The Company will not receive any proceeds from the Offer for sale and all proceeds will go to the Selling Shareholders.
Suraksha Diagnostic IPO GMP (Grey Market Premium)
To check real-time Grey Market Premium (GMP on IPO) of Suraksha Diagnostic, please visit the IPO GMP page.
Suraksha Diagnostic Subscription Status
This IPO subscription kicks off on November 29, 2024! Meanwhile, if you’re looking to stay updated with the latest subscription figures, head over to our IPO Subscription section for real-time data on all ongoing IPOs. Moreover, don’t miss out on the action—track the progress as it happens!
Suraksha Diagnostic Allotment Status
To check the Suraksha Diagnostic IPO allotment status, visit the IPO registrar website Kfin Technologies or go to the IPO Allotment page.
IPO Registrar
Kfin Technologies Limited
Selenium Building, Tower-B, Plot No 31 & 32,
Financial District, Nanakramguda, Serilingampally,
Hyderabad, Rangareddi, Telangana India – 500 032.
Phone: 04067162222, 04079611000
Email: sdl.ipo@kfintech.com
Website: www.kfintech.com
IPO Lead Managers
- Nuvama Wealth and Investment Limited
Suraksha Diagnostic Contact
Suraksha Diagnostic Limited
Plot No. DG-12/1, Action Area 1D, Premises No. 02-0327,
New Town, Rajarhat, Kolkata 700 156, West Bengal, India
Phone: +91 33 66059750
Email: investors@surakshanet.com
Website: www.surakshanet.com
FAQs
When will the Suraksha Diagnostic IPO open for subscription?
The IPO is set to open on November 29, 2024, for QIB, NII, and retail investors, and will close on December 3, 2024.
What is the price band for Suraksha Diagnostic IPO?
The price band for Suraksha Diagnostic IPO is set between ₹420 to ₹441 per equity share.
What is the minimum investment required for Suraksha Diagnostic IPO?
The minimum investment for Suraksha Diagnostic is ₹14,994 with 34 Shares.
When will the Suraksha Diagnostic shares be allotted?
The allotment date for Suraksha Diagnostic is December 4, 2024.
When will the Suraksha Diagnostic shares be listed?
The listing date for Suraksha Diagnostic is December 6, 2024.
Note: Suraksha Diagnostic IPO price band and date have been officially announced. Suraksha Diagnostic IPO Grey Market Premium (GMP) will be added to the IPO GMP page as soon as it becomes available.
Stay updated with the latest IPO news on Bapukhabar. Explore key pages like IPO GMP for the latest (Grey Market Premium) GMP on IPO, IPO Listing for recent and upcoming listings on NSE & BSE, IPO Subscription for real-time subscription data, IPO Allotment to check your allotment status, IPO Forms for application details, and SME IPO for updates on Small and Medium Enterprise IPOs.
Follow us on Instagram, Facebook, and Twitter for instant updates and more!
